IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,650,561 | -22.4% | 293,041 | -7.8% | 0.01% | -16.7% |
| Q2 2023 | $5,995,358 | +447.1% | 317,719 | +11.3% | 0.01% | +500.0% |
| Q1 2023 | $1,095,879 | -23.8% | 285,385 | -1.6% | 0.00% | -50.0% |
| Q4 2022 | $1,438,921 | +8.4% | 290,105 | +4.5% | 0.00% | +100.0% |
| Q3 2022 | $1,327,000 | +14.7% | 277,669 | +8.0% | 0.00% | 0.0% |
| Q2 2022 | $1,157,000 | -9.8% | 257,045 | -4.5% | 0.00% | 0.0% |
| Q1 2022 | $1,282,000 | -34.8% | 269,250 | +1.6% | 0.00% | 0.0% |
| Q4 2021 | $1,965,000 | +38.2% | 264,886 | +5.6% | 0.00% | 0.0% |
| Q3 2021 | $1,422,000 | -10.3% | 250,921 | +4.3% | 0.00% | 0.0% |
| Q2 2021 | $1,586,000 | -23.0% | 240,689 | -5.4% | 0.00% | 0.0% |
| Q1 2021 | $2,061,000 | -13.5% | 254,556 | -31.1% | 0.00% | 0.0% |
| Q4 2020 | $2,382,000 | +82.1% | 369,439 | +1.6% | 0.00% | 0.0% |
| Q3 2020 | $1,308,000 | -30.8% | 363,518 | -11.5% | 0.00% | 0.0% |
| Q2 2020 | $1,891,000 | +429.7% | 410,923 | +292.7% | 0.00% | – |
| Q1 2020 | $357,000 | -38.4% | 104,635 | -7.9% | 0.00% | – |
| Q4 2019 | $580,000 | +141.7% | 113,615 | +14.3% | 0.00% | – |
| Q3 2019 | $240,000 | +29.0% | 99,441 | +16.0% | 0.00% | – |
| Q2 2019 | $186,000 | -46.2% | 85,701 | -32.9% | 0.00% | – |
| Q1 2019 | $346,000 | -42.4% | 127,794 | +2.2% | 0.00% | -100.0% |
| Q4 2018 | $601,000 | -56.0% | 125,023 | -13.4% | 0.00% | 0.0% |
| Q3 2018 | $1,367,000 | -26.0% | 144,432 | -23.9% | 0.00% | -50.0% |
| Q2 2018 | $1,847,000 | +31.9% | 189,834 | +42.6% | 0.00% | +100.0% |
| Q1 2018 | $1,400,000 | +71.1% | 133,159 | +4.2% | 0.00% | 0.0% |
| Q4 2017 | $818,000 | -25.5% | 127,793 | -10.9% | 0.00% | 0.0% |
| Q3 2017 | $1,098,000 | +19.7% | 143,437 | +11.2% | 0.00% | 0.0% |
| Q2 2017 | $917,000 | +222.9% | 128,981 | +75.3% | 0.00% | – |
| Q1 2017 | $284,000 | -24.5% | 73,568 | -60.1% | 0.00% | – |
| Q4 2016 | $376,000 | -9.8% | 184,451 | +18.6% | 0.00% | – |
| Q3 2016 | $417,000 | -24.6% | 155,465 | -13.3% | 0.00% | -100.0% |
| Q2 2016 | $553,000 | -41.4% | 179,392 | +61.9% | 0.00% | 0.0% |
| Q1 2016 | $944,000 | +31.8% | 110,776 | +109.9% | 0.00% | 0.0% |
| Q4 2015 | $716,000 | +5.4% | 52,768 | -25.5% | 0.00% | 0.0% |
| Q3 2015 | $679,000 | -73.0% | 70,848 | -59.5% | 0.00% | -50.0% |
| Q2 2015 | $2,518,000 | +119.3% | 175,126 | +36.6% | 0.00% | +100.0% |
| Q1 2015 | $1,148,000 | +1.1% | 128,221 | -31.1% | 0.00% | 0.0% |
| Q4 2014 | $1,136,000 | +86.5% | 186,169 | +223.6% | 0.00% | – |
| Q3 2014 | $609,000 | -77.5% | 57,537 | -74.8% | 0.00% | -100.0% |
| Q2 2014 | $2,709,000 | +9.9% | 228,725 | +38.4% | 0.00% | 0.0% |
| Q1 2014 | $2,466,000 | +54.3% | 165,210 | +51.7% | 0.00% | +100.0% |
| Q4 2013 | $1,598,000 | -19.0% | 108,919 | -6.0% | 0.00% | -50.0% |
| Q3 2013 | $1,972,000 | +104.4% | 115,901 | +99.1% | 0.00% | +100.0% |
| Q2 2013 | $965,000 | +0.1% | 58,198 | -3.1% | 0.00% | 0.0% |
| Q1 2013 | $964,000 | – | 60,046 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |